Art

J-GLOBAL ID：201902249624897501   Reference number：19A1324030

Activity of Nivolumab and Utility of Neutrophil-to-Lymphocyte Ratio as a Predictive Biomarker for Advanced Non-Small-Cell Lung Cancer: A Prospective Observational Study

進行性非小細胞肺癌の予測バイオマーカーとしてのニボルマブの活性と好中球-リンパ球比の有用性:前向き観察研究【JST・京大機械翻訳】

Author (13)： Fukui Tomoya (Department of Respiratory Medicine, Kitasato University School of Medicine, Kanagawa, Japan) ,  Okuma Yuriko (Department of Respiratory Medicine, Kitasato University School of Medicine, Kanagawa, Japan) ,  Nakahara Yoshiro (Department of Respiratory Medicine, Kitasato University School of Medicine, Kanagawa, Japan) ,  Otani Sakiko (Department of Respiratory Medicine, Kitasato University School of Medicine, Kanagawa, Japan) ,  Igawa Satoshi (Department of Respiratory Medicine, Kitasato University School of Medicine, Kanagawa, Japan) ,  Katagiri Masato (Department of Medical Laboratory, Kitasato University School of Allied Health Sciences, Kanagawa, Japan) ,  Mitsufuji Hisashi (Fundamental Nursing, Kitasato University School of Nursing, Kanagawa, Japan) ,  Kubota Masaru (Department of Respiratory Medicine, Kitasato University School of Medicine, Kanagawa, Japan) ,  Hiyoshi Yasuhiro (Department of Respiratory Medicine, Kitasato University School of Medicine, Kanagawa, Japan) ,  Ishihara Mikiko (Department of Respiratory Medicine, Kitasato University School of Medicine, Kanagawa, Japan) ,  Kasajima Masashi (Department of Respiratory Medicine, Kitasato University School of Medicine, Kanagawa, Japan) ,  Sasaki Jiichiro (Research and Development Center for New Medical Frontiers, Kitasato University School of Medicine, Kanagawa, Japan) ,  Naoki Katsuhiko (Department of Respiratory Medicine, Kitasato University School of Medicine, Kanagawa, Japan)
Material： Clinical Lung Cancer
Volume： 20  Issue： 3  Page： 208-214.e2  Publication year： 2019 
JST Material Number： W3210A  ISSN： 1525-7304  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Abstract/Point： The immune checkpoint inhibito...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A1324030&from=J-GLOBAL&jstjournalNo=W3210A") }}

Thesaurus term： *biomarker ,  *non-small cell lung cancer ,  effectiveness ,  clinical trial ,  Prognosis ,  confidence interval ,  *Neutrophils ,  *forecast ,  drug therapy ,  *lymphocyte ,  *Advanced non-small cell lung cancer ,  adverse reaction ,  one year survival rate
Semi thesaurus term： 予後不良 ,  有害事象 ,  1年全生存率 ,  *ニボルマブ , 【Automatic Indexing@JST】

Author keywords (5)： Clinical practice ,  Immune checkpoint inhibitor ,  Immunotherapy ,  Prognosis ,  Programmed death-ligand 1

JST classification (2)： Tumors(=neoplasms)of respiratory system  (GI04000G) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C)

Terms in the title (10)： 進行性非小細胞肺癌 ,  予測 ,  バイオマーカー ,  ニボルマブ ,  活性 ,  好中球 ,  リンパ球 ,  有用性 ,  観察 ,  研究